Shanghai Henlius Biotech Inc. is a leading biopharmaceutical company focusing on developing, manufacturing and commercializing high-quality and affordable biologic medicines. The company's mission is to provide accessible and innovative treatments for patients worldwide. Henlius is committed to advancing the field of biotechnology through cutting-edge research and development in the areas of oncology, autoimmune diseases, and other therapeutic areas.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#307 in Shanghai

#3,471 in China

Shanghai, China

Shanghai Henlius Biotech Inc.

Forward Citations = 2

11 inventors:

Weidong Jiang (5 out of 5 patents)

Pei-Hua Lin (5 out of 6 patents)

Chi-Ling Tseng (4 out of 6 patents)

4. Wei-Dong Jiang (3 out of 3 patents)

5. Jiin-Tarng Wang (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shanghai Henlius Biotech Inc.. Retrieved from https://idiyas.com/company/shanghai-henlius-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]